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background: The major mode of death in patients with renal dysfunction (RD) is cardiovascular disease (CVD). Notably, there may be a causal 
effect of RD given that myocardial necrosis/apoptosis has been seen in animal models of RD. However, RD is also a marker of overall CVD severity. 
Cardiac transplantation provides an opportunity to study this as hearts are being transplanted in and out of the environment of RD: If irreversible 
myocardial damage occurs immediately with RD, as seen in animal models of acute kidney injury, transplantation of a heart from a donor with RD 
should yield reduced graft survival. However, if cardiac damage from RD develops gradually, transplantation of a healthy RD-free donor heart into a 
recipient with RD should yield an initial low risk period followed by high event rates months to years later.
Methods: Adult cardiac allograft recipients in the UNOS registry were studied (n=35,914). RD was defined as estimated glomerular filtration rate 
(eGFR) < 60 ml/min/1.73m2.
results: RD was present in 17.2 % of donors and 39.4% of recipients with an overall worsening in eGFR over time in recipients (p<0.001). Donor 
characteristics known to cause or reflect myocardial damage such as ischemic time > 4 hours (adjusted HR 1.2, p<0.001), age > 50 years (adjusted 
HR=1.3, p<0.001), or ejection fraction ≤ 45% (adjusted HR 1.2, p=0.03) were associated with reduced graft survival. To the contrary, the risk 
associated with RD did not follow the heart as transplantation from a donor with RD did not reduce graft survival (adjusted HR=0.98, p=0.44). RD-
free donor hearts placed into a recipient with RD paradoxically had the highest risk of graft dysfunction in the first 30 post-operative days (Adjusted 
HR 1.6, p<0.001). Subsequently, the hazard attributable to recipient RD (adjusted HR 1.2, p<0.001) did not increase over time (p=0.8) as would be 
expected with slow accumulation of myocardial damage from RD.
conclusion: Transplantation of a heart in and out of the environment of RD was not associated with worsened outcomes in a manner consistent 
with a clinically meaningful direct effect of RD on the myocardium. These data provide additional support that RD primarily serves as a marker rather 
than a direct cause of CVD.
